Back to Directory
Last Updated: 11/06/2026
Scripta Therapeutics
Oxford
Founded 2024
Transcription factor-targeting drug discovery for neurodegeneration
Scripta Therapeutics is an Oxford-based biotech company developing disease-modifying therapeutics by mapping and modulating transcription factor networks.
Its platform integrates AI, imaging, and patient-derived models in a lab-in-the-loop workflow to identify compounds that restore healthy cellular states.
The initial focus is Alzheimer's disease and other neurodegenerative conditions.
The company emerged from stealth in late 2025 with a $12m seed round led by Oxford Science Enterprises and Apollo Health Ventures.